Design and baseline characteristics of a cohort study in Japanese patients with hypercholesterolemia: the Japan lipid intervention trial (J-LIT)
暂无分享,去创建一个
Y. Matsuzawa | K. Shimamoto | M. Matsuzaki | T. Kita | J. Sasaki | H. Mabuchi | S. Oikawa | Yasushi Saito | N. Nakaya | H. Itakura | Y. Saito | Y. Saito
[1] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.
[2] P. Macfarlane,et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia , 1995 .
[3] W. Kannel,et al. Cigarette smoking and HDL cholesterol: the Framingham offspring study. , 1978, Atherosclerosis.
[4] M. Marmot,et al. Changes in total serum cholesterol and other risk factors for cardiovascular disease in Japan 1980-1989. , 1993, International journal of epidemiology.
[5] Manning Feinleib,et al. Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.
[6] A. Alberts,et al. Discovery, biochemistry and biology of lovastatin. , 1988, The American journal of cardiology.
[7] R. Collins,et al. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. , 1998, The New England journal of medicine.
[8] J. Patsch,et al. Triglyceride-rich lipoproteins and atherosclerosis. , 1994, Atherosclerosis.
[9] A. Folsom,et al. Serum fatty acids and fish intake in rural Japanese, urban Japanese, Japanese American and Caucasian American men. , 1989, International journal of epidemiology.
[10] K. Kodama,et al. Trend of coronary heart disease and its relationship to risk factors in a Japanese population: a 26-year follow-up, Hiroshima/Nagasaki study. , 1990, Japanese circulation journal.
[11] P. Wilson,et al. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.
[12] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[13] H. Iso,et al. Trends for coronary heart disease and stroke and their risk factors in Japan. , 1989, Circulation.
[14] H. Blackburn,et al. The seven countries study: 2,289 deaths in 15 years. , 1984, Preventive medicine.
[15] J. Neaton,et al. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). , 1986, JAMA.
[16] D. Labarthe,et al. Changes in cardiovascular disease risk factors in three Japanese national surveys 1971-1990. , 1996, Journal of epidemiology.
[17] D. Grafnetter,et al. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators. , 1978, British heart journal.
[18] T. Omae,et al. Changing Pattern of Cardiovascular Disease in the Japanese Population in Relation to Hypertension Control Programs , 1990, Journal of cardiovascular pharmacology.
[19] M Halperin,et al. Correlations of Plasma High‐density Lipoprotein Cholesterol Levels with Other Plasma Lipid and Lipoprotein Concentrations: The Lipid Research Clinics Program Prevalence Study , 1980, Circulation.
[20] S. Yusuf,et al. Report of the Conference on Low Blood Cholesterol: Mortality Associations , 1992, Circulation.
[21] D. Reed,et al. Plasma Lipids and Lipoproteins in Elderly Japanese‐American Men , 1986, Journal of the American Geriatrics Society.
[22] A. Gotto,et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. Air Force/Texas Coronary Atherosclerosis Prevention Study. , 1998, JAMA.
[23] M. Karvonen,et al. A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. , 1979, British heart journal.
[24] H. Iso,et al. Epidemiology of cerebrovascular disease: stroke epidemic in Japan. , 1996, Journal of epidemiology.
[25] B. Davis,et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. , 1996, The New England journal of medicine.